Replies to post #142578 on PharmaCyte Biotech Inc (PMCB)

[thenewmixer]

PMCB day range 10.8 - 13.63 not 15.00 still below split value. and IND still rejected

[oldmusky]

There is no phase 2b trial. There never will be.

The extremely deficient IND was put on hold and PMCB was given a lengthy list that will never be completed. The FDA is not interested in this therapy.

There will be no Nasdaq. PMCB has had quarter after quarter of 0 revenue. They simply do not qualify, and never will.

Big Pharma, if they were interested, would have made a move long ago. They have not.

This is just a group of aging Execs getting salaries and putting out pump PRs and nothing more.

A trial that has never happened cannot be successful.